BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31304685)

  • 1. Stretchable ECM Patch Enhances Stem Cell Delivery for Post-MI Cardiovascular Repair.
    Kim IG; Hwang MP; Park JS; Kim SH; Kim JH; Kang HJ; Subbiah R; Ko UH; Shin JH; Kim CH; Choi D; Park K
    Adv Healthc Mater; 2019 Sep; 8(17):e1900593. PubMed ID: 31304685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells.
    Sullivan KE; Quinn KP; Tang KM; Georgakoudi I; Black LD
    Stem Cell Res Ther; 2014 Jan; 5(1):14. PubMed ID: 24460869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.
    Efraim Y; Sarig H; Cohen Anavy N; Sarig U; de Berardinis E; Chaw SY; Krishnamoorthi M; Kalifa J; Bogireddi H; Duc TV; Kofidis T; Baruch L; Boey FYC; Venkatraman SS; Machluf M
    Acta Biomater; 2017 Mar; 50():220-233. PubMed ID: 27956366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.
    Singelyn JM; Sundaramurthy P; Johnson TD; Schup-Magoffin PJ; Hu DP; Faulk DM; Wang J; Mayle KM; Bartels K; Salvatore M; Kinsey AM; Demaria AN; Dib N; Christman KL
    J Am Coll Cardiol; 2012 Feb; 59(8):751-63. PubMed ID: 22340268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.
    Wang Z; Long DW; Huang Y; Chen WCW; Kim K; Wang Y
    Acta Biomater; 2019 Mar; 87():140-151. PubMed ID: 30710713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.
    Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL
    Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural myocardial ECM patch drives cardiac progenitor based restoration even after scarring.
    Sarig U; Sarig H; de-Berardinis E; Chaw SY; Nguyen EBV; Ramanujam VS; Thang VD; Al-Haddawi M; Liao S; Seliktar D; Kofidis T; Boey FYC; Venkatraman SS; Machluf M
    Acta Biomater; 2016 Oct; 44():209-220. PubMed ID: 27545814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
    Yan W; Guo Y; Tao L; Lau WB; Gan L; Yan Z; Guo R; Gao E; Wong GW; Koch WL; Wang Y; Ma XL
    Circulation; 2017 Nov; 136(22):2162-2177. PubMed ID: 28978553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction.
    Wang Q; Yang H; Bai A; Jiang W; Li X; Wang X; Mao Y; Lu C; Qian R; Guo F; Ding T; Chen H; Chen S; Zhang J; Liu C; Sun N
    Biomaterials; 2016 Oct; 105():52-65. PubMed ID: 27509303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model.
    Xiang Q; Liao Y; Chao H; Huang W; Liu J; Chen H; Hong D; Zou Z; Xiang AP; Li W
    Stem Cell Res Ther; 2018 Feb; 9(1):51. PubMed ID: 29482621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ECM Patch Combines Poly(vinyl alcohol), Human Fibroblast-Derived Matrix, and Mesenchymal Stem Cells for Advanced Wound Healing.
    Ha SS; Song ES; Du P; Suhaeri M; Lee JH; Park K
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4266-4275. PubMed ID: 33463354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
    Mewhort HE; Turnbull JD; Meijndert HC; Ngu JM; Fedak PW
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1650-9. PubMed ID: 24075463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
    Fan Z; Fu M; Xu Z; Zhang B; Li Z; Li H; Zhou X; Liu X; Duan Y; Lin PH; Duann P; Xie X; Ma J; Liu Z; Guan J
    Biomacromolecules; 2017 Sep; 18(9):2820-2829. PubMed ID: 28731675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats.
    Xu X; Xu Z; Xu Y; Cui G
    Coron Artery Dis; 2005 Jun; 16(4):245-55. PubMed ID: 15915077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction.
    Wu K; Wang Y; Yang H; Chen Y; Lu K; Wu Y; Liu C; Zhang H; Meng H; Yu Q; Zhang Y; Shen Z
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2578-2589. PubMed ID: 36598791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair.
    Jang J; Park HJ; Kim SW; Kim H; Park JY; Na SJ; Kim HJ; Park MN; Choi SH; Park SH; Kim SW; Kwon SM; Kim PJ; Cho DW
    Biomaterials; 2017 Jan; 112():264-274. PubMed ID: 27770630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placenta hydrogel reduces scarring in a rat model of cardiac ischemia and enhances cardiomyocyte and stem cell cultures.
    Francis MP; Breathwaite E; Bulysheva AA; Varghese F; Rodriguez RU; Dutta S; Semenov I; Ogle R; Huber A; Tichy AM; Chen S; Zemlin C
    Acta Biomater; 2017 Apr; 52():92-104. PubMed ID: 27965171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.